Arkolith/Insider Trading/TRVI/Form 4

Delfini Lisa

Chief Financial OfficerTrevi Therapeutics, Inc. (TRVI) · full profile →Form 4 · filed May 24, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$11K
Net Open-Market Flow
-$11K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 22, 2024Option exercise(M)16K$0.51$8K58K
May 22, 2024Sell(S)4K$2.64$11K53K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 22, 2024Option exercise(M)16K—$048K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-064598) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML